Patient Newsletter 2025 September

Cancer Q&A with HOA: Prostate Cancer Awareness

When it comes to care during cancer treatment, patients like to know they’re in good hands and can trust the professionals serving them. That’s exactly what those at Hematology Oncology Associates of Central New York are all about.

Patient Newsletter 2025 August

Breast, STML-ELA-0422 “ELEGANT”

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.

Patient Newsletter 2025 July

Pages